We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+15.53%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$38.7B
AUM Growth
+$5.1B
(+15%)
Cap. Flow
+$551M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
24.47%
Holding
1,486
New
101
Increased
869
Reduced
411
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$130M |
| 2 |
Franco-Nevada
FNV
|
+$128M |
| 3 |
B
Barrick Mining
B
|
+$98.9M |
| 4 |
Dominion Energy
D
|
+$96M |
| 5 |
Monolithic Power Systems
MPWR
|
+$88.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$133M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$104M |
| 3 |
SLB Ltd
SLB
|
+$90.4M |
| 4 |
Blackrock
BLK
|
+$89.1M |
| 5 |
Honeywell
HON
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 35.79% |
| 2 | Technology | 25.85% |
| 3 | Energy | 9% |
| 4 | Healthcare | 6.56% |
| 5 | Financials | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Omnicell
OMCL
$1.71B
| $43K | ﹤0.01% |
855
+296
| +53% | +$17.8K |
|
1327
American Vanguard Corp
AVD
$70.4M
| $42K | ﹤0.01% |
1,957
+99
| +5% | +$2.21K |
|
1328
Clearway Energy Class C
CWEN
$4.99B
| $41K | ﹤0.01% |
1,289
+552
| +75% | +$18.6K |
|
1329
Embecta
EMBC
$220M
| $39K | ﹤0.01% |
1,537
| – | – |
|
1330
Titan International
TWI
$466M
| $39K | ﹤0.01% |
2,535
| – | – |
|
|
FOLD
1331
DELISTED
Amicus Therapeutics
FOLD
| $36K | ﹤0.01% |
2,988
+981
| +49% | +$11K |
|
1332
Itron
ITRI
$4.42B
| $36K | ﹤0.01% |
712
+303
| +74% | +$15K |
|
1333
Mission Produce
AVO
$1.13B
| $35K | ﹤0.01% |
2,982
+353
| +13% | +$5.43K |
|
1334
Sundial Growers
SNDL
$320M
| $35K | ﹤0.01% |
16,794
+1,526
| +10% | +$3.63K |
|
1335
Cohen & Steers
CNS
$4.35B
| $33K | ﹤0.01% |
509
+28
| +6% | +$1.76K |
|
1336
Seneca Foods Class A
SENEA
$1.15B
| $32K | ﹤0.01% |
+530
| New | +$32.6K |
|
|
BERY
1337
DELISTED
Berry Global Group, Inc.
BERY
| $32K | ﹤0.01% |
568
| – | – |
|
1338
GrowGeneration
GRWG
$88.3M
| $31K | ﹤0.01% |
7,837
+1,127
| +17% | +$5.38K |
|
1339
Brookfield Renewable
BEP
$10.2B
| $30K | ﹤0.01% |
1,200
| – | – |
|
1340
Ameresco
AMRC
$1.2B
| $29K | ﹤0.01% |
514
+225
| +78% | +$13.7K |
|
1341
Green Plains
GPRE
$1.16B
| $28K | ﹤0.01% |
917
+448
| +96% | +$13.8K |
|
1342
Methanex
MEOH
$4.2B
| $28K | ﹤0.01% |
739
+81
| +12% | +$2.97K |
|
1343
Vital Farms
VITL
$548M
| $27K | ﹤0.01% |
1,788
+199
| +13% | +$2.75K |
|
1344
Ginkgo Bioworks
DNA
$585M
| $26K | ﹤0.01% |
381
+62
| +19% | +$5.7K |
|
1345
VanEck Emerging Markets High Yield Bond ETF
HYEM
$521M
| $26K | ﹤0.01% |
1,426
+1,201
| +534% | +$20.8K |
|
1346
Phreesia
PHR
$697M
| $26K | ﹤0.01% |
810
+234
| +41% | +$6.35K |
|
|
PRMW
1347
DELISTED
Primo Water Corporation
PRMW
| $26K | ﹤0.01% |
1,650
+216
| +15% | +$3.14K |
|
1348
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.77B
| $25K | ﹤0.01% |
1,052
+881
| +515% | +$20.7K |
|
1349
Maravai LifeSciences
MRVI
$947M
| $24K | ﹤0.01% |
1,681
-2,799
| -62% | -$44.1K |
|
1350
Cipher Digital
CIFR
$9.86B
| $22K | ﹤0.01% |
39,862
-504,267
| -93% | -$439K |
|
Similar funds
VanEck Associates's Q4 2022 Portfolio in Review
As of Q4 2022, VanEck Associates held 1,486 positions worth $38.7B, up 15% from $33.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
VanEck Associates's Q4 2022 filing shows 101 new, 869 increased, 411 reduced and 62 closed positions. Its largest new stake was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M. The largest sale was Gilead Sciences, an estimated $133M.
By sector, the portfolio is most concentrated in Materials at 36% of assets, up from 34% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q4 2022 buy was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M.
- VanEck Associates added most to Newmont in Q4 2022, an estimated $130M increase.
- VanEck Associates's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $133M.
- VanEck Associates fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q4 2022, selling an estimated $29.4M.
- VanEck Associates's ten largest holdings make up 24% of its $38.7B portfolio in Q4 2022.
- VanEck Associates opened 101 new positions and closed 62 in Q4 2022.
- VanEck Associates's portfolio value rose 15% quarter-over-quarter to $38.7B.
Based on VanEck Associates's 13F filing for Q4 2022, filed 8 Feb 2023.